Service alert

TV Anchor Puts Cameras on Pathologists During Cancer Diagnosis

11/04/2026
Podcast

November 4, 2026

Did You Know? Hospitals Store Your Tissue Samples for 10 Years in a Pathology Vault | firstcoastnews.com

Americans Open to AI in Healthcare but Want Human Oversight | Pew Research Center

Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression | Nature Genetics

HOME – CAP26

Elizabeth McMahon

Coming up, cameras track a tissue sample from the OR to the pathology lab in a real-time look at a Florida TV anchor's breast cancer journey. Plus, slow your role AI, a new Pew Research Survey on Americans' wary view of the tool in healthcare. Welcome to CAP News for Wednesday, November 4th. I'm Elizabeth McMahon of the College of American Pathologists. Here's what's making news in pathology and laboratory medicine. How does pathology play out in real time when patients are in surgery? Florida news anchor Jeannie Blaylock recently gave her Jacksonville area audience a first-hand look with the help of CAP member Dr. Shadi Qasem's. Dr. Qasem's is Chief of Pathology for Baptist Health System and has been helping Blaylock share parts of her breast cancer diagnosis and treatment this year. TV cameras followed Blaylock's tissue sample from the OR into Dr. Qasem's's lab for rapid processing.

Jeannie Blaylock

Two sentinel lymph nodes and breast tissue. And the clock is ticking for answers. What we want to avoid is basically ticking off all the boxes of all the possible types of lab tests that could present in a patient with slightly abnormal bleeding factors and or a suspected bleeding history. So this is the frozen section room.

Dr. Shadi Qasem

This is uh where we do rapid processing of specimens.

Jeannie Blaylock

Are the margins clear? My surgeon needs a phone call in the OR. Did she take out enough or not?

Elizabeth McMahon

Dr. Qasem confirmed some cancer cells in the tumor's margins and then helped Blaylock understand pathologists' next steps after surgery, including slide preparation, staining, and examination. He also took her deep into the hospital's slide vault to show her where samples are kept for future reference. The inside look at pathologists' work gave Blaylock new perspective on the pressures of the job. A lot of pressure on you. But that's why you love your job.

Dr. Shadi Qasem

Yes, yes. What you say is gonna affect people's lives and change their prognosis and future. It's huge. It's a lot of responsibility, uh, but at the same time, there is some satisfaction in finding the right diagnosis. It's almost like solving a puzzle, and sometimes I'm like, yes, we got it, we have the right answer.

Elizabeth McMahon

The prognosis for Blaylock's ductal carcinoma in situ is excellent, and she will continue to take her viewers into the laboratory and along for the ride as she recovers. A new Pew Research Center survey finds that Americans are open to using AI for certain healthcare tasks, but they still want a human touch. The study of nearly 3,500 U.S. adults found that most were okay with AI performing administrative tasks such as translating for patients and scheduling, but the largest shares still wanted humans to do a final review. More than half of those surveyed were also receptive to AI analyzing and explaining results from medical scans and lab tests with human oversight. But that openness fell away when it came to decisions that drive diagnoses or insurance decisions. About 46% say they do not want AI to have anything to do with making insurance claim decisions. And just 5% were open to AI making these calls on its own with no human review. Researchers from NYU Langone Health analyzed nearly half a million cells in tumors from patients with pancreatic ductal adenocarcinoma and found a diverse set of clones, which are clusters of tumor cells that have a similar genetic makeup. The clusters behaved differently. Some evolved to resist therapy, while others acquired the ability to spread rapidly. NYU researchers said the findings suggest that targeting the mechanisms underlying tumor evolution may restrain its progression. Analyzing single-cell clone clusters may also help understand complex cancers. On-demand access is now available to 42 sessions ranging from biopsies and tumor classification to leadership and lab testing. On-demand passes are available for purchase, and if you're an all-access pass holder, they are free. Earn CME credit for each course you complete, but be sure to plan ahead. On-demand access ends on January 31st. That's all for today. Be sure to check the show notes for the link to Cap 26 on demand and information on today's stories. Got a story you'd like to hear on the podcast? Write to us at stories at CAP.org. We're back at 5 AM Eastern for another episode of CAP News. I'm Elizabeth McMahon. Have a great day.